{"id":"https://openalex.org/W1910190157","doi":"https://doi.org/10.1111/j.1521-0391.2014.12126.x","title":"Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: A randomized study","display_name":"Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: A randomized study","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-15","ids":{"openalex":"https://openalex.org/W1910190157","doi":"https://doi.org/10.1111/j.1521-0391.2014.12126.x","mag":"1910190157","pmid":"https://pubmed.ncbi.nlm.nih.gov/24628830"},"language":"en","primary_location":{"id":"doi:10.1111/j.1521-0391.2014.12126.x","doi":"https://doi.org/10.1111/j.1521-0391.2014.12126.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1521-0391.2014.12126.x","pdf_url":null,"source":{"id":"https://openalex.org/S134700381","display_name":"American Journal on Addictions","issn_l":"1055-0496","issn":["1055-0496","1521-0391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal on Addictions","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1910190157"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011232306","display_name":"Thomas G. Schnell","orcid":"https://orcid.org/0000-0003-4622-0095","observed_orcids":["https://orcid.org/0000-0003-4622-0095"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Schnell","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy, University Hospital of Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy, University Hospital of Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103153746","display_name":"Dagmar Koethe","orcid":"https://orcid.org/0000-0002-8324-6756","observed_orcids":["https://orcid.org/0000-0002-8324-6756"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dagmar Koethe","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]},{"raw_affiliation_string":"University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068184338","display_name":"Anna Krasnianski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Krasnianski","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]},{"raw_affiliation_string":"University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089615489","display_name":"Stefanie Kristiane Gairing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefanie Gairing","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]},{"raw_affiliation_string":"University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040109787","display_name":"Knut Schnell","orcid":"https://orcid.org/0000-0003-0630-0146","observed_orcids":["https://orcid.org/0000-0003-0630-0146"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Knut Schnell","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]},{"raw_affiliation_string":"University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042119216","display_name":"J\u00f6rg Daumann","orcid":"https://orcid.org/0000-0002-6310-1787","observed_orcids":["https://orcid.org/0000-0002-6310-1787"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J\u00f6rg Daumann","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]},{"raw_affiliation_string":"University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033767146","display_name":"Euphrosyne Gouzoulis\u2010Mayfrank","orcid":"https://orcid.org/0000-0003-0632-4578","observed_orcids":["https://orcid.org/0000-0003-0632-4578"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Euphrosyne Gouzoulis\u2010Mayfrank","raw_affiliation_strings":["Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychotherapy University Hospital of Cologne Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]},{"raw_affiliation_string":"University Hospital of Cologne Department of Psychiatry and Psychotherapy Cologne Germany","institution_ids":["https://openalex.org/I4210153755"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5033767146"],"corresponding_institution_ids":["https://openalex.org/I4210153755"],"apc_list":{"value":3920,"currency":"USD","value_usd":3920},"apc_paid":null,"fwci":4.3591,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.94413508,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"23","issue":"3","first_page":"308","last_page":"312"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9909999966621399},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cannabis-use-disorder","display_name":"cannabis use disorder","score":0.8960000276565552},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9480000138282776},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8669999837875366},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8700000047683716},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.9801899790763855},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.8649280071258545},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6891507506370544},{"id":"https://openalex.org/C2777056318","wikidata":"https://www.wikidata.org/wiki/Q79817","display_name":"Cannabis","level":2,"score":0.684140145778656},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5938935875892639},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5913292169570923},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5750994086265564},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5320625901222229},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.517570436000824},{"id":"https://openalex.org/C2910205722","wikidata":"https://www.wikidata.org/wiki/Q3743620","display_name":"Cannabis Dependence","level":4,"score":0.4672180414199829},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.46710434556007385},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4103717803955078},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3610052466392517},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32119274139404297},{"id":"https://openalex.org/C2776895053","wikidata":"https://www.wikidata.org/wiki/Q422917","display_name":"Cannabidiol","level":3,"score":0.16382694244384766}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002189","descriptor_name":"Marijuana Abuse","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D002189","descriptor_name":"Marijuana Abuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017831","descriptor_name":"Diagnosis, Dual (Psychiatry)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1521-0391.2014.12126.x","doi":"https://doi.org/10.1111/j.1521-0391.2014.12126.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1521-0391.2014.12126.x","pdf_url":null,"source":{"id":"https://openalex.org/S134700381","display_name":"American Journal on Addictions","issn_l":"1055-0496","issn":["1055-0496","1521-0391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal on Addictions","raw_type":"journal-article"},{"id":"pmid:24628830","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24628830","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal on addictions","raw_type":"Comparative Study"},{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:43959","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/43959/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F1066001417","display_name":"Pfizer Pharma","ror":"https://ror.org/00m8w3m39"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W100052691","https://openalex.org/W1795906718","https://openalex.org/W1973736931","https://openalex.org/W2015557371","https://openalex.org/W2018279494","https://openalex.org/W2041298004","https://openalex.org/W2043897975","https://openalex.org/W2059190226","https://openalex.org/W2061900306","https://openalex.org/W2067425226","https://openalex.org/W2067507716","https://openalex.org/W2067567375","https://openalex.org/W2079350859","https://openalex.org/W2098644261","https://openalex.org/W2116246373","https://openalex.org/W2131823335","https://openalex.org/W2143017662","https://openalex.org/W2162942237","https://openalex.org/W2171396692","https://openalex.org/W2993505372","https://openalex.org/W3125806355"],"related_works":["https://openalex.org/W2015557371","https://openalex.org/W2780453108","https://openalex.org/W2949548335","https://openalex.org/W2122519801","https://openalex.org/W2359900191","https://openalex.org/W3173895954","https://openalex.org/W4402840352","https://openalex.org/W2356750923","https://openalex.org/W2059190226","https://openalex.org/W2063932035"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVES:":[2],"Clozapine":[3,94],"is":[4,27],"considered":[5],"to":[6,42,71,81,143],"be":[7],"particularly":[8],"effective":[9],"in":[10,56,89,127,134,141,152],"the":[11,37,44,49,128,149],"treatment":[12,95,129],"of":[13,36,46,102,122,130,148],"dually":[14,153],"diagnosed":[15,154],"(DD)":[16],"patients":[17,63],"with":[18,48,64,98,110],"psychosis":[19],"and":[20,66,75,107,125,146],"substance":[21],"use":[22,26,86,132],"disorders.":[23],"However,":[24],"its":[25],"restricted":[28],"by":[29],"potentially":[30],"severe":[31],"side":[32,105],"effects.":[33],"The":[34],"aim":[35],"present":[38],"pilot":[39,117],"study":[40],"was":[41,87,96],"compare":[43],"effects":[45,106,121],"clozapine":[47,74,124],"newer":[50],"second":[51],"generation":[52],"antipsychotic":[53],"(SGA)":[54],"ziprasidone":[55,72,126],"DD-patients.":[57],"METHODS:":[58],"Thirty":[59],"(n":[60],"=":[61],"30)":[62],"schizophrenia":[65],"cannabis":[67,131],"abuse/dependence":[68],"were":[69,76],"randomized":[70],"or":[73],"followed":[77],"up":[78,80],"for":[79],"12":[82],"months.":[83],"RESULTS:":[84],"Cannabis":[85],"reduced":[88],"both":[90,123],"groups":[91],"during":[92],"follow-up.":[93],"associated":[97],"less":[99],"positive":[100],"symptoms":[101],"schizophrenia,":[103],"more":[104],"poorer":[108],"compliance":[109],"treatment.":[111],"CONCLUSIONS:":[112],"Results":[113],"from":[114],"this":[115],"small":[116],"RCT":[118],"suggest":[119],"beneficial":[120],"disorders":[133],"psychotic":[135],"patients.":[136],"Larger-scale":[137],"RCTs":[138],"are":[139],"needed":[140],"order":[142],"assess":[144],"advantages":[145],"disadvantages":[147],"different":[150],"SGAs":[151],"populations.":[155]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1910190157","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
